Impact of function-guided glioma treatment on oncological outcome in the elderly

Introduction: Many patients with high-grade gliomas (HGG) are of older age. Research question: We hypothesize that pre- and intraoperative mapping and monitoring preserve functional status in elderly patients while gross total resection (GTR) is the aim, resulting in overall survival (OS) rates comp...

Full description

Saved in:
Bibliographic Details
Main Authors: Carolin Albrecht, Lea Baumgart, Axel Schroeder, Benedikt Wiestler, Bernhard Meyer, Sandro M. Krieg, Sebastian Ille
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Brain and Spine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772529423010305
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850118741516353536
author Carolin Albrecht
Lea Baumgart
Axel Schroeder
Benedikt Wiestler
Bernhard Meyer
Sandro M. Krieg
Sebastian Ille
author_facet Carolin Albrecht
Lea Baumgart
Axel Schroeder
Benedikt Wiestler
Bernhard Meyer
Sandro M. Krieg
Sebastian Ille
author_sort Carolin Albrecht
collection DOAJ
description Introduction: Many patients with high-grade gliomas (HGG) are of older age. Research question: We hypothesize that pre- and intraoperative mapping and monitoring preserve functional status in elderly patients while gross total resection (GTR) is the aim, resulting in overall survival (OS) rates comparable to the general population with HGG. Material and methods: We subdivided a prospective cohort of 168 patients above 65 years with eloquent high-grade gliomas into four groups ([years/cases] 1: 65–69/58; 2: 70–74/47; 3: 75–79/43; 4: >79/20). All patients underwent preoperative noninvasive mapping, which was also used for decision-making, intraoperative neuromonitoring in 138 cases, direct cortical and/or subcortical motor mapping in 66 and 50 cases, and awake language mapping in 11 cases. Results: GTR and subtotal resection (STR) could be achieved in 65% and 28%, respectively. Stereotactic biopsy was performed in 8% of cases. Postoperatively, we found transient and permanent functional deficits in 13% and 11% of cases. Postoperative Karnofsky Performance Scale (KPS) did not differ between subgroups. Patients with long-term follow-up (51%) had a progression-free survival of 5.5 (1–47) months and an overall survival of 10.5 (0–86) months. Discussion and conclusion: The interdisciplinary glioma treatment in the elderly is less age-dependent but must be adjusted to the functional status. Function-guided surgical resections could be performed as usual, with maximal tumor resection being the primary goal. However, less network capacity in the elderly to compensate for deficits might cause higher rates of permanent deficits in this group of patients with more fast-growing malignant gliomas.
format Article
id doaj-art-89bb0af79e5c4330b5ca6829b1afcb82
institution OA Journals
issn 2772-5294
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Brain and Spine
spelling doaj-art-89bb0af79e5c4330b5ca6829b1afcb822025-08-20T02:35:47ZengElsevierBrain and Spine2772-52942024-01-01410274210.1016/j.bas.2023.102742Impact of function-guided glioma treatment on oncological outcome in the elderlyCarolin Albrecht0Lea Baumgart1Axel Schroeder2Benedikt Wiestler3Bernhard Meyer4Sandro M. Krieg5Sebastian Ille6Department of Neurosurgery, Technical University of Munich, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, GermanyDepartment of Neurosurgery, Technical University of Munich, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, GermanyDepartment of Neurosurgery, Technical University of Munich, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, GermanySection of Diagnostic and Interventional Neuroradiology Department of Radiology, Klinikum Rechts der Isar, School of Medicine, Technische Universität München, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany; Department of Diagnostic and Interventional Neuroradiology, Technical University of Munich, GermanyDepartment of Neurosurgery, Technical University of Munich, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, GermanyDepartment of Neurosurgery, Technical University of Munich, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, GermanyDepartment of Neurosurgery, Technical University of Munich, Germany; School of Medicine, Klinikum Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany; Corresponding author. Department of Neurosurgery, Technical University of Munich, Germany, School of Medicine, Klinikum rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany. New affiliation: Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, GermanyIntroduction: Many patients with high-grade gliomas (HGG) are of older age. Research question: We hypothesize that pre- and intraoperative mapping and monitoring preserve functional status in elderly patients while gross total resection (GTR) is the aim, resulting in overall survival (OS) rates comparable to the general population with HGG. Material and methods: We subdivided a prospective cohort of 168 patients above 65 years with eloquent high-grade gliomas into four groups ([years/cases] 1: 65–69/58; 2: 70–74/47; 3: 75–79/43; 4: >79/20). All patients underwent preoperative noninvasive mapping, which was also used for decision-making, intraoperative neuromonitoring in 138 cases, direct cortical and/or subcortical motor mapping in 66 and 50 cases, and awake language mapping in 11 cases. Results: GTR and subtotal resection (STR) could be achieved in 65% and 28%, respectively. Stereotactic biopsy was performed in 8% of cases. Postoperatively, we found transient and permanent functional deficits in 13% and 11% of cases. Postoperative Karnofsky Performance Scale (KPS) did not differ between subgroups. Patients with long-term follow-up (51%) had a progression-free survival of 5.5 (1–47) months and an overall survival of 10.5 (0–86) months. Discussion and conclusion: The interdisciplinary glioma treatment in the elderly is less age-dependent but must be adjusted to the functional status. Function-guided surgical resections could be performed as usual, with maximal tumor resection being the primary goal. However, less network capacity in the elderly to compensate for deficits might cause higher rates of permanent deficits in this group of patients with more fast-growing malignant gliomas.http://www.sciencedirect.com/science/article/pii/S2772529423010305ElderlyGlioblastomaMappingNeuromonitoringTms
spellingShingle Carolin Albrecht
Lea Baumgart
Axel Schroeder
Benedikt Wiestler
Bernhard Meyer
Sandro M. Krieg
Sebastian Ille
Impact of function-guided glioma treatment on oncological outcome in the elderly
Brain and Spine
Elderly
Glioblastoma
Mapping
Neuromonitoring
Tms
title Impact of function-guided glioma treatment on oncological outcome in the elderly
title_full Impact of function-guided glioma treatment on oncological outcome in the elderly
title_fullStr Impact of function-guided glioma treatment on oncological outcome in the elderly
title_full_unstemmed Impact of function-guided glioma treatment on oncological outcome in the elderly
title_short Impact of function-guided glioma treatment on oncological outcome in the elderly
title_sort impact of function guided glioma treatment on oncological outcome in the elderly
topic Elderly
Glioblastoma
Mapping
Neuromonitoring
Tms
url http://www.sciencedirect.com/science/article/pii/S2772529423010305
work_keys_str_mv AT carolinalbrecht impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly
AT leabaumgart impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly
AT axelschroeder impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly
AT benediktwiestler impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly
AT bernhardmeyer impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly
AT sandromkrieg impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly
AT sebastianille impactoffunctionguidedgliomatreatmentononcologicaloutcomeintheelderly